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8INTRODUCTION
Eustachian tube dysfunction is widely recognised as the triggering 
factor   of middle ear disease. Though it happens to be the important 
factor for various middle ear problems, Eustachian tube function tests are 
not routinely done. Eustachian tube dysfunction predisposes the ear for 
chronic middle ear disease and it is a cause for concern to ENT Surgeon 
as the success rate of surgery is less when performed in ear with impaired 
tubal function. Eustachian tube function’s role in successful outcome of 
surgeries for chronic otitis media has become a topic of interest in recent 
years.
There are various methods to test the functioning of Eustachian
tube. Pneumatic otoscopy, Eustachian tube cathetarisation ,Valsalva 
manoeuvre, Politzer’s test , Toynbee test ,Impedance audiometry 
,Imaging ,Inflation-Deflation method and Sonotubometry are the 
methods available for testing the function of Eustachian tube. Testing the 
pressure regulation function of Eustachian tube by modern impedance 
audiometers is an non-invasive simple cost effective method for
identifying Eustachian tube dysfunction.
9Recent studies show that the success rates of tympanoplasty were 
found to be lesser when surgery was done in ears having  poor tubal 
function compared to ears with normal Eustachian tube function. These 
studies have made surgeons realise the importance of Eustachian tube and 
testing the functioning of Eustachian tube.
      Patient’s  with mucosal type of chronic otitis media (COM) are 
classified into healed COM ,inactive COM and active COM. Patients 
with tympanosclerosis and healed perforation are grouped under healed 
COM. In inactive mucosal COM there is a permanent perforation of the 
pars tensa but the middle ear mucosa is not inflamed. Active mucosal 
disease is where there is a permanent defect of the pars tensa with an 
inflammed middle ear mucosa which produces mucopus that may 
discharge. Testing  the functioning of Eustachian tube  in  patients  with  
COM  and addressing the treatable causes of Eustachian tube  
dysfunction before tympanoplasty increases  the  success rate of the 
surgery.
This study was performed to find the functioning of Eustachian 
tube in normal adults and those with middle ear disease. This study was 
done in Department of ENT, Coimbatore Medical College Hospital 
,Coimbatore in patients  with normal tympanic membrane , in COM 
patients with dry central  perforation, in patients with retracted tympanic 
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membrane and in patients with healed central perforation. Post operative 
patients who underwent myringoplasty and type 1 tympanoplasty were 
also   tested for Eustachian tube function. 
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OBJECTIVES OF THE STUDY:
 To evaluate Eustachian tube function in normal adults .
 To test the functioning of Eustachian tube in patients with dry 
central perforation.
 To compare ET functioning of normal adults with patients having 
chronic otitis media.
 To find out whether it is important in healing of tympanic 
membrane in patients with central perforation.
 To evaluate its role in outcome of  Myringoplasty and Type 1 
Tympanoplasty.
 To evaluate its role in patients with retracted tympanic 
membrane.
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REVIEW OF LITERATURE
The Eustachian tube otherwise known as pharyngotympanic tube 
connects the middle ear space with the Nasopharynx. The Eustachian 
tube (ET), middle ear, and mastoid cavity are spaces within the head, 
lined with respiratory epithelium and functioning in many ways like the 
respiratory sinuses. Consequently, the ET, ear, and sinuses share many 
similar types of mucosal physiology and pathology.
Three important physiologic functions of the ET are 
(1) regulation of the middle ear pressure, 
(2) protection of the middle ear and 
(3) clearance of the middle ear space 1.
It is a well established fact that eustachian tube dysfunction (ETD) 
is an important factor in the causation and progression of chronic 
secretory otitis media2. ETD can also cause  more invasive diseases. 
When the tubal mechanism fails, either in passive or active function, it 
leads to a series of events in the middle ear space that varies from a mild 
retraction to fulminate cholesteatoma.
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HISTORY
Bartolomeus Eustachius, for whom the ET is named is the first 
researcher of the Eustachian tube in modern era .He was a 16th century 
anatomist who taught at the Collegia della Sapienza in Italy. Eustachius, 
studied all areas of the human body and described Eustachian tube in
detail 3.
Further work was done by Antonio Valsalva, (1666-1723). 
Valsalva was a anatomist at Bologna and known  for valsalva manoeuvre 
which tests the ET function by middle ear insufflation. Valsalva named 
the auditory tube, the Eustachian tube, and described its function in 
detail4.
Adam Politzer is a pioneer in the field of otology and probably 
considered as the greatest otologist of the nineteenth century. One of his 
important inventions was a hand-held air bag that allowed insufflation of 
the middle ear space also known as politzerization, as the inventor termed 
it. For therapeutic purpose he developed a primitive middle ear 
ventilation tube 5.
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EMBRYONIC DEVELOPMENT
The development of the eustachian tube and middle ear occurs as 
an out pouching of the pharynx that forms the tubotympanum and the 
pneumatised temporal bone.6 The cartilaginous portion of the eustachian 
tube undergoes the majority of the growth seen in utero.1 During 
development the ET provides a continuous sheet of epithelial cells to 
create the middle ear lining.7
The main difference between mucosa of the the middle ear and the 
ET mucosa is that the epithelium of the ET differentiates into respiratory 
epithelium (pseudostratified ciliated columnar), whereas the middle ear 
epithelium does not. However, simple nonciliated cuboidal epithelium is 
present in the posterior part of the middle ear8. This distinction found in 
ET mucosa provides a more effective, inherent protective component. 
Unique characteristics of the ET include the presence of more mucus 
cells and accessory glands when compared with the middle ear mucosa 9.
Compared with adults, the position of the infant ET is 10 degrees 
from the Frankfort horizontal plane. This angle is different in adults 
whose tube is positioned at a 45 degrees.1 Among other differences in 
adult and pediatric ETs, a less angled ET in the pediatric population has 
been thought to be responsible for the increased incidence of middle ear 
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pathology. However,some researchers have found that active muscle 
function, rather than passive clearance and impedance of the ET, is 
responsible for the decreased disease state seen in adults. 10,11\
A smaller or partially obstructed ET does not necessarily correlate 
with the risk of disease or even active disease. Using an in vivo model, 
Sade and coworkers12 in 2004 found that narrowing of the ET alone did 
not prohibit natural gas flow into the middle ear space with a swallowing 
manoeuvre. Although the narrowed ET was open for a brief period, this 
was sufficient to overcome a negative pressure.
ANATOMY
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The length of the ET has been reported to be between 31 and 38 
mm. 13 The normal orientation of the ET is downward, anterior, and with 
a medial rotation. With this positioning, the ET creates an angle of about 
45 degrees and 30 to 40 degrees with the sagittal and horizontal planes, 
respectively .9
The Eustachian tube is made up of bone, cartilage, and fibrous 
tissue. The bony component is approximately 12 mm in length, whereas 
the cartilaginous is about 24 mm in length. This longer portion is 
described as a triangular plate of elastic fibrocartilage. The base of the 
tube forms the torus tubarius, which is posterior to the nasopharyngeal 
opening the eustachian tube 9.
Blood supply to the Eustachian tube and its supporting structures 
originates from the deep auricular branches of the internal maxillary 
artery, the ascending palatine artery and the ascending pharyngeal 
artery14.
Sensory and motor innervation of the Eustachian tube is supplied 
by a branch from the otic ganglion,the pharyngeal plexus from branches 
of the glossopharyngeal nerve and sphenopalatine nerve. Sympathetic 
branches innervate the Eustachian tube from the sphenopalatine ganglion, 
glossopharyngeal nerve, otic ganglion, petrosal nerves and the 
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carticotympanic nerve. Parasympathetic innervation is from the tympanic 
branch of the glossopharyngeal nerve 1,14.
MUSCLES OF THE ET
Four muscles are associated with the ET, which through a complex 
interaction; assist with equilibrating middle ear pressure. These muscles 
are:
1. Tensor veli palatini, 
2. Levator veli palatini, 
3. Salpingopharyngeus, and
4. Tensor tympani.
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The tensor veli palatini (TVP) is a thin muscle lateral to the levator 
veli palatini. The medial portion of this muscle is the primary dilator of 
the Eustachian tube. The origin of the muscle arises from three locations. 
One origin is at the base of the medial pterygoid plate on the scaphoid 
fossa. The second is from the spina angularis of the sphenoid, and the 
third is from the lateral wall of the cartilaginous eustachian tube. The 
Tensor veli palatini muscle descends and inserts on a tendon at the 
pterygoid hamulus 9,15.
Levator veli palatini is a thicker muscle compared with the Tensor 
veli palatini and lies lateral to the choanae. Its origin is from two 
anatomic sites. The first is the inferior surface of the apex of the petrous 
part of temporal bone. The second origin is the medial lamina of the 
cartilage of the Eustachian tube. The muscle extends above the superior 
pharyngeal constrictor merging with the opposite levator muscle at 
midline 9,15.
Salpingopharyngeus originates from the inferior portion of the 
Eustachian tube extending downward joining the pharyngopalatinus 
muscle and assists with elevation of the pharynx and opening of the 
Eustachian tube with deglutition 9,15. 
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Tensor tympani is a large muscle encased in a bony canal above 
the osseous portion of the Eustachian tube. The tensor tympani origin 
involves three locations .The first is the cartilaginous portion of the ET, 
and the second is the greater wing of the sphenoid. The third is 
attachments to the bony canal in which the muscle travels. The tensor 
tympani insertion is at the manubrium of the malleus 9,15.
ANATOMIC  FEATURES  OF  
EUSTACHIAN  TUBE
IN  THE  INFANT, AS  
COMPARED  WITH  ADULT  , 
IT  IS
Length  of  the  tube shorter
Angle  of  the  tube 10 A0    vs   45 A0
Angle  of  tensor  veli  palatine  
muscle  to  cartilage
Variable  vs  Stable
Cartilage  cell  density Greater
Lumen Smaller  area
Mucosal  folds Greater 
Ostmann  pad  of  fat  Wider
Cartilage  volume & middle ear 
volume
Less 
Elastin at  hinge  portion  of  
cartilage
Less 
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FUNCTIONS OF THE  EUSTACHIAN TUBE
Normally, the ET stays closed and opens when necessary to 
equalize pressure. Other functions include clearance of middle ear fluid 
while at the same time preventing nasopharyngeal secretions refluxing 
into the middle ear space.
1.Ventilation and regulation of middle ear pressure16
For normal hearing, it is essential that pressure on two sides of the 
tympanic membrane is equal. Negative or positive pressure in the middle 
ear affects hearing .Eustachian tube has to open periodically to equilibrate 
the air pressure in the middle ear with ambient pressure. Normally, the 
Eustachian tube remains closed and opens intermittently during 
swallowing, yawning and sneezing. Posture also affects the function; 
tubal opening is less efficient in recumbent position and during sleep due 
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to venous engorgement. Tubal function is also poor in infants and young 
children and thus responsible for more ear problems in that age group. It 
usually normalizes by the age of 7-10 years.17-19
2. Protective functions. 
Abnormally, high sound pressures from the nasopharynx can be 
transmitted to the middle ear if the tube is open thus interfering with 
normal hearing. Normally, the eustachian tube remains closed and 
protects the middle ear against these sounds.20
A normal eustachian tube also protects the middle ear from reflux 
of nasopharyngeal secretions into the middle ear. This reflux occurs more 
readily if the tube is wide in diameter (patulous tube), short in length, (as 
in babies) or the tympanic membrane is perforated (cause for persistence 
of middle ear infections in cases of tympanic membrane perforations).
High pressures in the nasopharynx can also force nasopharyngeal 
secretions into the middle ear, e.g. forceful nose blowing, closed-nose 
swallowing as in the presence of adenoids or bilateral nasal obstruction.
3. Clearance or drainage
Mucous membrane of the Eustachian tube and anterior part of the 
middle ear is lined by ciliated columnar epithelium. The cilia beat in the 
direction of nasopharynx. This helps to clear the secretions and debris in 
22
the middle ear towards nasopharynx. The clearance is further augmented 
by active opening and closing of the tube. 
Gas exchange between the middle ear cleft and the nasopharynx 
through the fibrocartilaginous Eustachian Tube
The fibrocartilaginous Eustachian tube has a valve-like function: in 
its cartilaginous portion the mucosal surfaces are in apposition during the 
rest position. The tubal muscles must actively dilate the tubal valve in 
order to obtain adequate gas transfer into the middle ear cleft, so gas 
exchanges may occur.
At first, in normal conditions, healthy mucosa, in a normal daily 
situation, the fibrocartilaginous Eustachian tube provides an intermittent 
supply of gas, by transfer into the middle ear cleft. This is a regular, 
periodic, active process of gas transfer. Currently it is considered that, in 
normal conditions and situations, gas transfer via the fibrocartilaginous 
Eustachian tube is relatively poor, compared with the delicate and 
perfectly controlled gas exchanges between the middle ear cleft and blood 
compartment, via the mucosa.
The amount of gas introduced into the middle ear cleft is relatively 
poor: being approximately one micro-litre, five thousand times a day. It 
means 5 ml a day.The duration of the intermittent opening of the lumen 
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of the fibrocartilaginous Eustachian tube has been estimated to be about 
three to four minutes a day.
A second situation occurs during normal conditions, healthy 
mucosa, but exposed to an exceptional situation: altitude, flying, diving, 
etc., or during an accidental situation, such as an explosion, for example. 
In all these cases, the fibrocartilaginous Eustachian tube plays the leading 
role in balancing out the variations of pressure in the middle ear cleft. It is 
a highly sophisticated valve of security. It serves as a release valve for 
excessive positive pressure in the middle ear cleft and by means of 
muscular forces, opens to equalize excessive negative pressure in the 
middle ear cleft.
A third situation occurs when the mucosa undergoes an 
inflammatory process. The fibrocartilaginous Eustachian tube no longer 
balances the exchanges of gases between the middle ear cleft and the 
blood compartment. This means that with regard to the gas supply to the 
middle ear cleft, the main process occurs at the level of the middle ear 
cleft mucosa.
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ETIOLOGY OF  EUSTACHIAN TUBE DYSFUNCTION
Multiple causes of ET dysfunction exist. This varied differential 
includes infectious, allergic, mechanical (obstructive), environmental 
exposure, genetic, reflux, congenital, and iatrogenic causes. 
Upper respiratory tract infection
Eustachian tube is commonly affected by viral upper respiratory 
tract infections (URIs).Healthy tubal function decreased the risk of 
complications resulting from URI.21
Chronic sinusitis 
Chronic sinusitis is one of the most common cause for Eustachian 
tube dysfunction. Chronic sinusitis causes inflammation around the 
Eustachian tube opening in the Nasopharynx and over a period of time 
causes permanent change in mucociliary clearance and pressure 
regulation. Patients who had undergone endoscopic sinus surgery had 
relief of their otologic symptoms related to Eustachian tube dysfunction.22
Allergic rhinitis
Allergy induced changes in the epithelial lining of Eustachian tube 
and middle ear mucosa is well documented23,24 .Allergic rhinitis with 
viral infections  interact to enhance the physiologic responses of  the 
middle ear and ET 25.
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Adenoid hypertrophy
Adenoid enlargement obstructs the nasopharyngeal opening of the 
ET and  it can also impair mucociliary clearance from the tube by means 
of metaplasia of ciliated epithelium to nonciliated epithelium and fibrosis 
of connective tissue associated with adjacent adenoid tissue 26.
Tobacco smoke
Two studies published by Agius and coworkers27,28, confirmed that 
there was a decrease in ciliary beat frequency of the mucosa of the 
Eustachian tube in smokers compared with nonsmokers. This finding, 
however, has been tempered by work by Coggins and colleagues29 and 
Antonelli and coworkers30 who found passive tobacco smoke in the 
animal model to have little effect on otitis media. According to Dubin and 
coworkers 31, passive smoke does affect the  Eustachian tube function, but 
may play only part of a role in causing middle ear disease.
Reflux
Gastro oesophageal reflux disease is one of the important cause of 
ET dysfunction and recent studies have confirmed it beyond doubt. White 
and coworkers32 determined that not only exposure to gastric contents in 
the nasopharynx caused a significant ET dysfunction in an animal model,
it also disabled middle ear pressure regulation and mucociliary clearance 
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of middle ear contents. Heavner and coauthors33 in 2001 had previously 
published similar results in an animal model.
Cleft palate
Children with a cleft palate have an increased risk of middle ear 
pathology 34. The incidence of ETD has been quoted as high as 79% in 
patients with cleft palate and cleft lip/palate 35.
Arnold and coworkers found patients with bilateral cleft palate to 
have a nearly horizontal course of the ET, possibly worsening symptoms. 
Although Tensor veli palatini muscle had a bony attachment on either 
side, the levator veli palatini muscle showed an abnormal course. This 
finding led the investigators to conclude that, during contraction, an 
aberrant obstruction of the ET may result. 
Unfortunately, some cleft patients continue to have Eustachian tube 
dysfunction postoperatively and as they grow into adulthood. One third 
of the adults in a 2006 study by Gudziol and Mann 36 with cleft lip and 
palate had persistent  tubal dysfunction.
Radiation
Treatment of nasopharyngeal malignancies with external beam 
radiation has detrimental effects on the surrounding structures, especially 
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the ET. Multiple investigators have found patients with early and late 
middle ear pathologies secondary to iatrogenic ET injury 37–39.
Reduced mastoid air cell system
The presence of a mastoid air cell system has been reported as an 
important criterion postoperatively to act as a pressure buffering system. 
However, this function is dependent on having healthy mastoid mucosa40. 
Nitrous oxide
A study by Teixeira and coworkers41 in 2005 found that 
approximately one half of patients who received 50% nitrous oxide under 
general anesthesia, had Type C tympanograms postoperatively, compared 
with a Type A tympanogram preoperatively. This change in middle ear 
pressure is likely secondary to absorption of nitrous oxide, leaving a 
decrease in gaseous volume in the middle ear space.
EUSTACHIAN TUBE FUNCTION TESTS
Assessment can be started initially by taking a thorough history. A 
typical Eustachian tube dysfunction patient will complain of fullness or 
clogging of the ears, pain or discomfort, hearing loss, tinnitus, and 
dizziness. Most concerning to these patients is when these symptoms 
cannot be relieved by swallowing, yawning, or chewing. 
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Some researchers have reported that tests for evaluating ET 
function are not reliable 42. However, most agree that there are objective 
and subjective assessments helpful in studying  Eustachian tube 
dysfunction.
1.Pneumatic otoscopy 
Using pneumatic otoscopy, an examiner can evaluate the mobility 
of the tympanic membrane. Stiffness or middle ear effusions are 
suggestive of Eustachian tube dysfunction. 
2.Nasopharyngoscopy
Nasopharyngoscopy, represents another manner to visually inspect 
the posterior nasopharynx and proximal opening of the ET. Pathology 
such as adenoid hypertrophy or mucosal edema can be seen. It is well 
known that a rigid or flexible nasal endoscope allows the examiner to 
visualize the nasopharyngeal opening of the ET. Usually 30 degree or 70 
degree rigid Hopkins rod endoscopes provide the best visualization. Other 
researchers have advocated using 0.8-mm flexible fiberscopes to evaluate 
beyond the isthmus of the ET and even into the middle ear cleft. 43,44
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3. Tympanometry 
Tympanometry is based on a simple principle, i.e. when a sound 
strikes tympanic membrane, some of the sound energy is absorbed while 
the rest is reflected .A stiffer tympanic membrane would reflect more of 
sound  energy  than a compliant one. By changing    the pressures in  a 
sealed  external   auditory  canal  and  then measuring  the  reflected  
sound  energy, it  is  possible  to find the compliance  or  stiffness  of  the  
tympano-ossicular  system and thus find  the  healthy  or  diseased  status  
of   the middle ear.
Essentially, the equipment consists of a probe which snugly fits 
into the external auditory canal and. has three channels; 
(i) to deliver a tone of 220 Hz,
(ii) to pick up the reflected sound through a microphone and 
(iii) to bring about changes in air pressure in the ear canal  from 
positive to normal and then negative. By charting the 
compliance of tympano-ossicular system against various 
pressure changes, different types of graphs called 
tympanograms are obtained which are diagnostic of certain 
middle ear pathologies.
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Types of tympanograms
1.Type A Normal tympanogram.
2.Type As Compliance is lower at or near ambient air pressure. Seen 
in  fixation  of    ossicles, e.g. otosclerosis  or  malleus  
fixation.
3.Type Ad High compliance at or near ambient pressure.Seen in 
ossicular discontinuity or thin and lax tympanic 
membrane. 
4.Type B A flat or dome-shaped graph. No change in compliance
with pressure changes. Seen in middle ear fluid or thick 
tympanic membrane.
5.Type C Maximum compliance occurs with negative pressure in 
excess of 100 mm of H2O. Seen in retracted tympanic 
membrane 
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TYPE  OF  TYMPANOGRAM DESCRIPTION
PEAKED
A
C1
C2
Between  +200 and -99 da pa
Between  -100 and -199 da pa
Between -200 and -399 da pa
NON PEAKED
B No  observable  peak  between  
+200  and  -600 da pa
Tympanometry has also been used to find function of eustachian 
tube in cases of intact or perforated tympanic membrane . A negative or a 
positive pressure (- 200 or + 200 mm of H20) is created in the middle ear 
and the person is asked to swallow 5 times in 20 seconds. The ability to 
equilibrate the pressure indicates normal tubal function. The test can also 
be used to find the patency of the grommet placed in the tympanic 
membrane in cases of serous otitis media45.
4. Valsalva test
The principle of this test is to build positive pressure in the 
Nasopharynx so that air enters the eustachian tube. To do this test, patient 
pinches his nose between the thumb and index finger, takes a deep breath, 
closes his mouth and tries to blow air into the ears. If air enters the middle 
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ear, the tympanic membrane will move outwards which can be verified 
by otoscope or the microscope. In the presence of a tympanic membrane 
perforation, a hissing sound is produced or if discharge is also present in 
the middle ear, cracking sound will be heard. 
Failure of this test does not prove blockage of the tube because 
only about 65% of persons can successfully perform this test. This test 
should be avoided in the presence of atrophic scar of tympanic membrane 
which can rupture, and in the presence of infection of nose and 
nasopharynx where infected secretions are likely to be pushed into the 
middle ear causing otitis media.
5.Toynbee test
While valsalva tests positive pressure, Toynbee's manoeuvre 
causes negative pressure. It is a more physiological test. It is performed 
by asking the patient to swallow while nose has been pinched. This draws 
air from the middle ear into the nasopharynx and causes inward 
movement of tympanic membrane which is verified by the examiner 
otoscopically or with a microscope. Another variant of Toynbee test is 
equilibration of pressure generated by impedance audiometer by repeated 
swallowing which is an important method of testing  tubal function in 
perforated ear drum46.
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6. Politzer test
In the Politzer test, one of the patient’s nostrils is occluded with a 
rubber balloon as the examiner pinches the other nostril tightly. The 
patient elevates the palate by swallowing or phonating. The examiner 
then forces air into the closed nasal cavity from Politzer’s bag. Air can be 
heard going into the middle space with an auscultation device. The 
examiner can also visually compare the tympanic membrane before and 
after the procedure to determine its relative patency 47.
7.Radiological test. 
A radio-opaque dye, e .g . hypaque or lipoidal instilled into the 
middle ear through a pre-existing perforation, and X-rays taken should 
delineate the tube and any obstruction. The time taken by the dye to reach 
the nasopharynx  also indicate  its clearance function. This test is no 
longer popular now.
8.Catheterisation. 
First  nose is  anaesthetised by topical spray of lignocaine and then 
a Eustachian tube catheter, the tip of which is bent, is passed along the 
floor of nose till it reaches the nasopharynx. Here it is rotated 90 degree 
medially and gradually pulled back till it engages on the posterior border 
of nasal septum. It is then rotated 180 degree  laterally so that the tip lies 
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against the tubal opening . A Politzer's bag is now connected to the 
catheter and air insufflated. Entry of air in to the middle ear is verified by 
an auscultation tube. 
The procedure of catheterization should be gentle as it is known to 
cause complications such as:
a) Injury to eustachian tube opening which causes  scarring later.
b) Bleeding from the nose.
c) Transmission of nasal and nasopharyngeal infection into the 
middle ear causing otitis media.
d) (d) Rupture of atrophic area of tympanic membrane if   too much 
pressure is used.
8. Saccharine or methylene blue test. 
Saccharine solution is placed into the middle ear through a pre-
existing perforation. The time taken by it to reach the pharynx and impart 
a sweet taste is also a measure of clearance function. Similarly, 
methylene blue dye can be instilled into the middle ear and the time taken 
by it to stain the pharyngeal secretions can be noted. Indirect evidence of 
drainage/clearance function is established when ear drops instilled into 
the ear with tympanic membrane perforation cause bad taste in throat.42
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9.Bluestone’s nine-step test. 
Another method of measuring Eustachian tube function is an 
inflation-deflation test developed by Bluestone48, although the applied 
middle-ear pressures are limited in magnitude. This test is currently used 
to test Eustachian tube function when the tympanic membrane is intact. 
The middle ear must be free of effusion.
The nine-step tympanometry procedure  may be summarized as follows:
1. The tympanogram records resting middle-ear pressure.
2. Ear canal pressure is increased to +200 mm H2O with medial 
deflection of the tympanic membrane and a corresponding increase 
in middle-ear pressure. The subject swallows to equilibrate middle-
ear overpressure.
3. While the subject refrains from swallowing, ear canal pressure is 
returned to normal, thus establishing a slight negative middle-ear 
pressure (as the tympanic membrane moves outward). The 
tympanogram documents the established middle-ear under
pressure.
4. The subject swallows in an attempt to equilibrate negative middle-
ear pressure. If equilibration is successful, airflow is from the 
nasopharynx to the middle ear.
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5. . The tympanogram records the extent of equilibration.
6. Ear canal pressure is decreased to -200 mm H2O, causing a lateral 
deflection of the tympanic membrane and a corresponding 
decrease in middle-ear pressure. The subject swallows to 
equilibrate negative middle-ear pressure; airflow is from the 
nasopharynx to the middle ear.
7. The subject refrains from swallowing while external ear canal 
pressure is returned to normal, thus establishing a slight positive 
pressure in the middle ear as the tympanic membrane moves 
medially. The tympanogram records the overpressure established.
8. The subject swallows to reduce overpressure. If equilibration is 
successful, airflow is from the middle ear to the nasopharynx.
9. The final tympanogram documents the extent of equilibration. The 
test is simple to perform, can give useful information regarding 
Eustachian tube function, and should be part of the clinical 
evaluation of patients with suspected Eustachian tube dysfunction. 
In general, most normal adults can perform all or some parts of this 
test, but even some normal children have difficulty in performing 
it. However, if any patient can pass some or all of the steps, 
Eustachian tube function is considered good.
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10.Forced-Response Test
It is used  in   perforated tympanic membrane,and the middle ear 
should be free of  inflammation. It enables the study of both passive and 
active responses of the Eustachian tube. The contractions of the tensor 
veli palatine muscle causes active response as it displaces the lateral walls 
from the cartilage-supported medial wall of the tube. It can be determined 
whether ET dysfunction is due to the material properties of the ET or due 
to a defective active opening mechanism.
During this test, the middle ear is inflated at a constant flow 
rate,forcing the Eustachian tube open. After forcefully opening  the tube, 
the pump continues delivering a constant airflow maintaining a steady 
stream of air through the ET. Then the subject is instructed to swallow for 
assessment of the active dilatation of the tube.
The method is unique in that it eliminates the “mucous forces” in 
the Eustachian tube lumen that may interfere with the results of the 
inflation-deflation test when an attempt is made to assess the active 
opening mechanisms and the compliance of the tube. In this test, the 
passive resistance is assessed, and the active resistance is determined 
during swallowing. Patients with nonintact tympanic membranes as a 
result of chronic perforation or tympanostomy tubes can be distinguished 
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from apparently normal subjects with traumatic perforations of the 
tympanic membrane and negative otologic histories. The ratio of the 
passive and active resistance correctly differentiates a normally 
functioning Eustachian tube from an abnormally functioning one.
But van Heerbeek and colleagues49,50 compared the forced response 
test results with the pressure equalization test (inflation- deflation) in 
children who had tympanostomy tubes inplace and concluded that the 
pressure equalization test was more reliable over time than the forced-
response test because the latter showed a downward shift with repeated 
measurements.
11. Sonotubometry. 
A final testing mechanism is sonotubometery. In this procedure, a 
sound source is applied to the nostril as a microphone in the external 
auditory canal records the transmitted sound. Sound levels are measured 
as the ET opens and closes. The tone is heard louder when the tube is 
patent. It also tells the duration for which the tube remains open. It is a 
non -invasive technique and provides information on active tubal 
opening. Accessory sounds produced in the nasopharynx, during 
swallowing, may interfere with the test results. The advantage of this 
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diagnostic test is the ability to evaluate the ET with or without an intact 
membrane under physiologic conditions51.
MEDICAL MANAGEMENT OF ET DILATORY DYSFUNCTION
The treatment of ET dilatory dysfunction depends upon 
identification of the etiology. Most cases of tubal dysfunction are due to 
mucosal disease and can be improved if the underlying source of the 
inflammation can be identified and treated. 
The two most common etiologies seen in adult patients have been 
laryngopharyngeal reflux and allergic disease. The etiologies in children 
are still under investigation but reflux and allergies appear to play an 
important role. Infectious and environmental irritants may play a larger 
role in young children.
Laryngopharyngeal reflux should be treated with dietary 
modifications such as avoiding large meals within two hours of bedtime, 
avoiding foods that relax the lower esophageal sphincter (caffeine, 
carbonated beverages) and that promote acid production. Consideration 
should be given to acid reducing agents such as proton pump inhibitors 
preferably twice daily and H2 blockers at bedtime may be added. 
Refractory cases can be managed by sleeping on an inclined bed, and 
ultimately, fundoplication may be considered.
41
A careful history and physical examination for any evidence of 
allergic disease should be undertaken. Avoidance of offending allergens 
can be effective, but may not always be possible. Oral second-generation 
antihistamines, nasal steroid sprays, nasal antihistamine or mast cell 
stabilizer sprays, leukotriene inhibitors, or combination therapy may be 
effective in reducing allergic manifestations. Refractory cases may be 
helped with immunotherapy.
A thorough search for nasal, sinus, and any systemic inflammatory 
conditions should be done and appropriate therapy administrated. 
Recurrent infections should prompt a search for underlying nasal or sinus 
disease, immunosuppression or immunodeficiency, or primary mucosal 
disorders (e.g., Samter’s triad, Wegener’s disease, ciliary dysfunction). 
Granulomatous disease may be treated   with  immunosuppressants.
Anatomical obstructions are unusual causes of tubal dilatory 
dysfunction.Neoplasms, especially malignancy, should be suspected with 
unilateral dilatory dysfunction and the pathology may be nasopharyngeal 
carcinoma, lymphoma, chondrosarcoma, and others. Otitis media with 
effusion is the second most common presentation of nasopharyngeal 
carcinoma after a neck mass. The diagnosis of neoplasms is best done 
with contrast enhanced MRI or CT imaging. Other benign lesions that 
may cause tubal dilatory dysfunction may be adenoid hypertrophy, mucus 
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retention cysts, Thornwaldt’s cysts, or synechiae from adenoidectomy 
and other surgical procedures.
A hypertrophic adenoid pad does not need to cover the tubal orifice 
at rest to cause significant functional obstruction. During the swallowing 
process, contraction of the pharyngeal constrictors can compress an 
otherwise non-obstructive adenoid into the posterior surface of the 
posterior cushion of the ET and force it anteriorly to close the tubal 
orifice at the time it should be dilating open.
         Nguyen et al. demonstrated that adenoidectomy for relief of otitis 
media with effusion was most effective when adenoid tissue was in 
contact with the posterior cushions of the Eustachian tube orifices.52
These findings would be consistent with the dynamic observations of 
pharyngeal constriction acting to push the adenoid into the posterior 
cushions as a mechanism causing tubal dilatory dysfunction.
SURGICAL MANAGEMENT OF EUSTACHIAN TUBE 
DILATORY DYSFUNCTION
In the event that thorough investigation of underlying medical 
conditions and maximal medical therapy fails to resolve otitis media or 
atelectasis, surgical intervention may be indicated. 
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Tympanostomy tubes are effective in the treatment of otitis media 
with effusion and may prevent retraction of the eardrum, atelectasis, and 
other sequelae of ET dilatory dysfunction. In the event that non-infectious 
middle ear drainage or inflammation persists despite a tube in place, it 
raises the suspicion of a primary mucosal disorder rather than just a 
Eustachian tube problem. Thick proteinaceous ‘glue-like’ effusions that 
repeatedly occlude the lumen of the ventilating tube often will respond to 
oral or topical steroids and may represent primary mucosal disease. 
In cases of long-term persistent tubal dilatory dysfunction, repeated 
placement of ventilating tubes may be necessary. In such circumstances, 
larger flanged tubes, such as ‘T’ tubes or subannular semi-permanent 
tubes may be indicated. Longer duration tubes raise  the risk of 
permanent perforation of the tympanic membrane and development of 
squamous epithelial ingrowth from the perforation margins.
Gates 53 demonstrated that adenoidectomy is effective in children 
in resolving medically refractory otitis media with effusion and Nguyen52
noted that the benefit was most significant when the adenoid was in 
contact with posterior cushion or the ET orifice.
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For adult cases of medically refractory ET dilatory dysfunction 
who have received multiple tympanostomy tubes, Eustachian tuboplasty 
(ETP) is now being investigated. It is indicated for otitis media with 
effusion or non-adherent atelectasis when tubes have been the only other 
effective therapy. ETP appears to be most effective when the underlying 
medical conditions have been brought under control but there is 
irreversible mucosal disease causing functional obstructive dysfunction of 
dilation.
The hypothesis for the procedure is that debulking of the posterior 
cushion, which contains a thicker mucosal and submucosal surface than 
the anterolateral wall, may facilitate the muscular efforts to dilate the 
valve open. Laser or microdebrider tuboplasty with removal of redundant 
edematous tissue along the posteromedial Eustachian tube orifice has 
been shown to be an effective alternative for patients with chronic otitis 
media with effusion who have received numerous prior tympanostomy 
tubes with or without significant atelectasis.54,55,56
The operation involves debulking of the luminal mucosa and 
submucosa of the posterior cushion down to the medial cartilaginous 
lamina from the free margin at the nasopharyngeal opening and extending 
proximally up to the valve. The extent of valve mucosa treated depends 
on preoperative evaluation with slow motion video endoscopy to reveal 
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the dynamics of the functional obstruction. Debulking of the luminal side 
of the medial cartilaginous lamina, the cartilage within the posterior 
cushion, may increase the effectiveness of the operation.
The open defect is allowed to heal by secondary intention, a 
process that usually takes about six weeks. For that reason, a temporary 
tympanostomy tube is customarily inserted at the time of surgery. The 
ETP operation may be more efficacious in less severe cases of otitis 
media, non-adherent atelectasis, and patients prone to baro-injury with 
flights and scuba diving.
Metson et al.56 performed microdebrider ETP on adult patients 
simultaneously with endoscopic sinus surgery in twenty adult patients 
with otitis media with effusion, flat tympanograms, and sinus disease 
requiring surgical management. They noted that 70% improved 
subjectively and by tympanogram or pure tone average improvement of 
10 dB or more. 
Even after successful surgery, patients must remain vigilant about 
avoidance of offending agents or continuing medical therapy for their 
underlying condition. If they cease allergy or reflux precautions or 
therapy, the effusion may recur.
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Long-term results and controlled studies need to be done to 
determine the ultimate role of the procedure in the treatment of refractory 
otitis media. Further research must be done on the physiology and 
pathophysiology of tubal function in children before tuboplasty surgery 
would be recommended for pediatric patients.
CHRONIC OTITIS MEDIA
Chronic otitis media is any structural change in the middle ear 
system associated with a permanent defect in the tympanic membrane 
(TM). Usually, but not always, there is associated inflammatory 
mucosal disease in the middle ear, which may also involve the mastoid 
cells. If there is persistent   or intermittent otorrhea through a nonintact 
TM, the amplified designation“chronic suppurative otitis media” is 
preferred. The condition is considered “chronic” if the TM defect is 
present for a period greater than 3 months. Thus, a draining middle ear 
that is associated with a perforation from acute otitis media would not 
qualify for this diagnosis if it responds to treatment within 3 months. 
Histologically, COM is defined as irreversible mucosal changes within 
the middle ear cleft.
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There are two types of chronic otitis media – mucosal or 
tubotympanic type  & squamous or attico antral type .Patient’s  with 
mucosal type of chronic otitis media are classified into healed COM 
,inactive COM and active COM. Patients with tympanosclerosis and 
healed perforation are grouped under healed COM. In inactive mucosal 
COM there is a permanent perforation of the pars tensa but the middle ear 
mucosa is not inflamed. Active mucosal disease is where there is a 
permanent defect of the pars tensa with an inflammed middle ear mucosa 
which produces mucopus that may discharge.
The other type of COM is squamous type (active and inactive ).In 
inactive type there is retraction of the pars flaccida or pars tensa (usually 
posterosuperior) which has the potential to become active with retained 
debris .In active type there is retained squamous epithelial debris  with 
inflammation.
PERFORATIONS OF THE TYMPANIC MEMBRANE
Perforations of the TM are described according to their anatomic 
location and are separated into two categories. Central perforations 
involve the pars tensa and are circumferentially surrounded by residual 
TM. The umbo of the malleus is used as a reference point to divide the 
pars tensa into four quadrants, allowing one to describe the location of the 
48
perforation. Subtotal perforations describe large defects in which there is 
only a narrow rim of residual pars tensa near the annulus. 
Central perforations are rarely associated with cholesteatoma and 
for this reason have generally been considered “safe” ears. However, 
serious complications in the setting of a central perforation, such as 
intracranial abscess, have been reported.57 The term “tubotympanic 
disease” is sometimes used to describe COM with a central perforation. 
This term stems from the fact that the TM defect exposes both the middle 
ear mucosa and eustachian tube but generally does not produce 
inflammatory changes in the mastoid.
Marginal perforations have no remnant of Tympanic membrane
adjacent to the bone of the posterior canal wall. As a result, the bony 
external canal wall, attic, antrum, and mastoid cells can be involved with 
inflammation. Hence, this condition has been referred to as Atticoantral 
disease. Retraction pockets produce marginal perforations and also occur 
in the pars flaccida where  they are known to cause attic perforations. In 
addition, total perforations with complete loss of the pars tensa result 
from necrotizing otitis media.
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CHOLESTEATOMAS
Cholesteatomas are retraction pockets or cysts lined with squamous 
cell epithelium and filled with keratin debris occurring within the 
pneumatized spaces of the temporal bone. They are frequently associated 
with marginal perforations. The name is a misnomer as cholesteatoma is 
not a true neoplasm and does not contain cholesterol, but this familiar 
term retains wide popularity in clinical parlance.
Cholesteatomas have a propensity for growth, bone destruction, 
and chronic infection. Therefore, COM with cholesteatoma is considered 
an “unsafe” ear and generally requires surgical treatment.
Cholesteatomas are categorized as congenital or acquired. 
Congenital cholesteatomas appear as white pearly masses deep to normal, 
intact TMs. Prior history of otorrhea, perforation, or otologic procedures 
excludes this category.However, patients may have a prior history of 
uncomplicated acute otitis media.58
Acquired cholesteatomas are much more common and develop in 
the setting of a retracted or perforated TM. Primary acquired 
cholesteatomas arise from retracted but intact drumheads, most often 
within an attic. Secondary acquired cholesteatomas result from ingrowth 
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of squamous cell epithelium into the middle ear, usually through marginal 
perforations.
Cholesteatomas may also be described according to their anatomic 
location. Pars tensa cholesteatomas usually involve the posterosuperior 
quadrant of the TM and commonly cause erosion of the long process of 
the incus with discontinuity of the incudostapedial joint and conductive 
hearing loss. The disease frequently extends into the posterior tympanic 
spaces, facial recess, and sinus tympani.
Attic cholesteatomas arise from pars flaccida defects and tend to be 
associated with scutum defects owing to erosion of the outer wall of the 
epitympanum. The ossicles are frequently engulfed or eroded by the 
cholesteatoma, which may then extend into the mastoid antrum.
PATHOGENESIS  OF CHRONIC OTITIS MEDIA
Chronic otitis media is an insidious process, and patients tend to 
present with long-standing disease.As a result, the etiology and natural 
course of this  process remain obscure, although several credible theories 
have been advanced.
Traditionally, COM has been thought to follow a bout of acute 
otitis media (AOM) that resulted in TM perforation. However, this direct 
correlation has fallen out of favour for several reasons. First, AOM is one 
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of the most common childhood diseases. Comparatively speaking, COM 
is lesser in number. In addition, the majority of TM perforations 
secondary to AOM result in complete healing of the drumhead.59 Second, 
whereas streptococcal otitis media, which causes necrotizing infections 
resulting in large perforations, is seldom seen today, the incidence of 
COM has remained constant.60 Third, in a study of 200 patients  with TM 
perforations, only 50% clearly recalled an acute, painful ear infection 
associated with the onset of otorrhea. Instead, 40% described the 
insidious  onset of drainage or gradual hearing loss.
Although COM may not result directly from a  single episode of 
AOM, it has been suggested that all cases of otitis media represent 
different stages in a continuum of events.61–63 For example, histologic  
studies have demonstrated that persistent effusion in chronic secretory 
otitis media leads to degradation of the fibrous layer of the TM. Loss of 
the fibrous layer results in a weakened, atrophic, two-layered drumhead 
that is vulnerable to atelectasis or perforation and hence chronic middle 
ear disease.59,64
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ATELECTATIC AND ADHESIVE OTITIS MEDIA
It is acknowledged that eustachian tube dysfunction plays an 
important role in the development of COM.65 The eustachian tube serves 
to ventilate the middle ear so that pressure equalization occurs between 
this space and the surrounding environment.
In persisting eustachian tube dysfunction, especially as seen in 
Down syndrome and cleft palate, the middle ear space is continually 
exposed to negative pressure. As a result, the TM is retracted medially. In 
atelectatic or adhesive OM, the middle ear space is partially or 
completely obliterated. In long-standing atelectasis, patients are at risk for 
secondary acquired cholesteatomas.
Poor mastoid pneumatization is also associated with chronic 
middle ear disease.65 Although pneumatisation is not completed until 
adulthood, the majority  of the process takes place during the first 5 years 
of life. Infancy and early childhood infections occurring during this 
period are thought to prevent normal cellular development of the mastoid 
and thus lead to chronic middle ear disease. Temporal bone 
histopathologic studies also demonstrate that infection of a pneumatized 
cleft incites sclerosis, obliteration of air cells, and chronic middle ear 
disease in the setting of poor mastoid pneumatization.59
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Ventilating tubes can be placed within an atelectatic TM in an 
attempt to equalize the pressure and allow the TM to return to its normal 
anatomic position. Fifty percent of patients with pressure equalization 
tubes experience at least one episode of otorrhea, and 3% will have 
symptoms persisting beyond 6 weeks.66 After extrusion of the tube, the 
majority of iatrogenic TM perforations will heal. Residual perforation 
rates are 2 to 3% for button or grommet tubes but as high as 47% for T 
tubes.67,68 Continued eustachian tube dysfunction, persistent otorrhea, and 
ingrowth of squamous cell epithelium through the defect can prevent 
spontaneous healing.
CHRONIC OTITIS MEDIA ( MUCOSAL OR TUBOTYMPANIC 
TYPE)
Recurrent infections of the middle ear generally result in 
irreversible mucosal changes. Histologic  studies have shown that as the 
inflammatory process enters the chronic phase, there is a shift in cellular 
population from infiltrating leukocytes toward mononuclear cells such as 
macrophages, lymphocytes, and plasma cells.69 These mononuclear cells 
secrete inflammatory mediators and growth factors that increase capillary 
permeability and lead to edema and hyperemia of the middle ear mucosa.
54
In chronic inflammation, the mucosa undergoes metaplasia from a 
single layer of ciliated cuboidal or columnar epithelium to mucosa 
resembling that of the respiratory tract with increased numbers of goblet 
and glandular cells. Consequently, there is an increase in the volume and 
viscosity of the mucus. These changes further overwhelm the already 
compromised mucociliary clearance capability of patients suffering from 
chronic middle ear disease.69,70
Granulation tissue consisting of vascular connective tissue with 
inflammatory infiltrates has been found to be the prominent pathologic 
feature of COM. Granulation tissue was identified in over 95% of the 
temporal bones studied from individuals with a history of COM.71
Tympanosclerosis was present in 43%, cholesteatoma in 36%, and 
cholesterol granuloma in 21% of patients in one large histologic study of 
temporal bone pathology. A pathologic review of 800 temporal bones 
revealed that granulation tissue had both a higher prevalence and more 
generalized distribution when compared to cholesteatoma.72 Both studies 
demonstrated identical pathologic changes within the middle ear cleft 
regardless of the presence of a Tympanic membrane perforation. 
As granulation tissue matures, it becomes dense and fibrotic with 
decreased vascularity. This process leads to scarring and adhesions 
associated with the ossicular chain and Tymapnic membrane.73
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Irreversible changes such as subepithelial edema and mucoperiosteal 
fibrosis occur deep to the epithelial lining.74 As the inflammation persists, 
sclerosis, along with new bone formation, can cause a reduction in 
mastoid and antral pneumatization. 
ET, MASTOID, AND CHOLESTEATOMA
Progression of cholesteatomas is affected by the status of 
mastoid.sometimes mastoid status found to be  more important than ET 
dysfunction. Hasebe and coworkers 75 in 2001 compared three group of 
patients in different stages of tympanic membrane retraction. Three 
groups were as follows
1. Patients with a severe attic retraction pocket.
2. Patients with cholesteatoma who were conservatively treated, 
3. Patients with cholesteatoma who needed surgery. 
Though all three groups had Eustachian tube dysfunction, no 
significant difference in Eustachian tube function was identified among 
the three groups. Progression of the cholesteatoma appeared to be 
significantly associated with the ventilatory condition of the mastoid 
rather than the function of ET. Less aeration of mastoid system found in 
the surgery group compared with the nonsurgical group led to this 
observation 75.
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When the ET fails to equalize pressure, a negative pressure in the 
middle ear space occurs. The mastoid is seen by many researchers as a 
buffer zone for the middle ear and tympanic membrane allowing some 
equalization of this abnormal pressure. Cinamon and Sade 76 developed a 
model to evaluate how pressure homeostasis of the middle ear can be 
maintained. They found that the worst "model" for adapting to these 
changes was a middle ear space with a small mastoid. The investigators 
proposed that this anatomic finding may lead to patients developing 
compensatory buffering mechanisms, such as retraction or fluid 
accumulation, which  reduced  middle  ear  volume .
Retraction pockets are well known to result from Eustachian tube 
dysfunction. Wolfman and Chole 77 in 1986 found cauterized Eustachian 
tubes of the Mongolian gerbil resulted in a progressive retraction in 75% 
of the animal in a 16-week period.
Examining the retracted tympanic membrane, Paparella and co-
workers 78 described epithelial and subepithelial changes such as keratin 
accumulation,papillary growth, mucosal adhesion, irregular epithelium, 
and bone destruction. Although reasonable theories exist to describe why 
cholesteatomas occur, it is not entirely known what allows retraction 
pockets to evolve into cholesteatomas .
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Cholesteatomas are known to arise more commonly in the pars 
flaccida.The reason for this may be that there is poorer aeration in this 
area, especially in the area of the tympanic isthmus. Kobayashi and 
colleagues 79 in 1994 compared computed tomography scans of 53 
patients with retractions in the pars flaccida, including those with 
cholesteatoma. Their results found little association with this blockage 
and progression of a cholesteatoma.
SURGERY FOR CHRONIC OTITIS MEDIA
MYRINGOPLASTY
Myringoplasty is a procedure used to repair a tympanic membrane 
perforation, without the need to examine the middle-ear. 
The procedure should be limited to patients who satisfy all of the 
following four criteria:
1. Relatively small central perforation of the tympanic membrane
2. Translucent tympanic membrane
3. No middle-ear disease is present or suspected
4. Hearing is within normal limits
When these conditions are not met, a tympanoplasty is indicated to 
facilitate the repair and to explore the middle ear.
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TYMPANOPLASTY
A tympanoplasty, as opposed to only a myringoplasty, should be 
performed when there is a need to examine the middle ear, such as when 
there is conductive hearing loss that cannot be attributed to the size and 
position of the perforation (eg, ossicular discontinuity or fixation), when a 
retraction pocket is present, or when an occult middle-ear cholesteatoma 
is suspected.Additional indications would be when the perforation is 
large, when its location makes it difficult to repair using a myringoplasty 
procedure (eg, anterosuperior quadrant), or when it is a “marginal” 
perforation.
When the perforation is in the posterosuperior quadrant and is 
marginal, a tympanoplasty provides not only a higher success rate, but 
also an opportunity to inspect the ossicular chain and middle ear, 
especially the sinus tympani and facial recess, to rule out cholesteatoma.
CLASSIFICATION OF TYMPANOPLASTY  (WULLSTEIN -
1956)
The classification of tympanoplasty based on middle-ear 
mechanics, consists of five types, each of which is based on the most 
lateral intact structure that remains connected to the inner ear:
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Type I  tympanoplasty - TM is grafted to an intact ossicular chain
Type II tympanoplasty - Malleus is partially eroded .TM  is grafted to 
the incus
Type III tympanoplasty   -   Malleus and  incus are eroded .TM is grafted 
to the  stapes  suprastructure.
Type IV tympanoplasty - Stapes suprastructure is eroded but foot plate 
is mobile. TM is grafted to a mobile foot 
plate .
Type V Tympanoplasty - TM is grafted to a fenestration in the 
horizontal semicircular canaL
According to J. Sade (1976), the classification  of  tympanic  atelectasis  
has  4 grades:
Grade I            Mild TM retraction
Grade II           TM retraction in contact with incus or stapes 
Grade III         TM in contact with promontory wall (not adhered to it)
Grade IV         TM adhered to promontory (adhesive otitis media)
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MATERIALS AND METHODS
This study was done in the department of ENT, Coimbatore 
Medical College , Coimbatore from December 2012 to November 2013.  
It consists of 50 adults with normal tympanic membrane and 50 patients 
with chronic otitis media (inactive mucosal type). As a part of the study 
eustachian tube function was also evaluated in patients with retracted 
tympanic membrane ,healed central perforation and post operative 
patients who underwent myringoplasty or type 1 tympanoplasty . Age 
range was between 18 to 49 yrs.
Control group 
50 adults who came to ENT outpatient department for hearing 
assessment with normal hearing and normal tympanic membrane were 
subjected to Eustachian tube function tests. Prior consent was obtained 
from them before Eustachian tube function tests.
Study group
100 adult patients who visited ENT outpatient department with
middle ear disease were subjected to Eustachian tube function tests.\
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Inclusion criteria
Chronic otitis media with dry central perforation including post 
operative patients with residual perforation
1. Retracted pars tensa of tympanic membrane (grade 1 & 2)
2. Healed central perforation 
3. Post operative patients who underwent myringoplasty or type 1 
tympanoplasty before  3 months
Exclusion criteria
1. Patients with active ear discharge & middle ear mucosal 
inflammation
2. Post operative patients who underwent surgery within three months
3. Retracted pars tensa of tympanic membrane (grade 3 & 4)
4. Patients with upper respiratory tract infection 
5. Patients with squamous type of chronic otitis media
6. Patients with structural abnormality like cleft palate
7. Age below 18 years and above 49 years
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A detailed history was recorded for all patients. Past surgical 
history was elicited in detail. Ear examination including tuning fork tests 
and video otoscopy was done for all patients. Other clinical examinations 
like nasal, oral cavity examination were  done.
All patients were subjected to pure tone audiometry and graphical 
recording of their hearing threshold were made and pure tone average in 
both ears were recorded. Tympanometry was done in all patients.
Eustachian tube function was assessed by Valsalva test, pneumatic 
otoscopy (siegalization), nasopharyngoscopy & tympanometry.
Eustachian tube function was assessed with impedance audiometer 
with two tests. William’s test was done in patients with intact tympanic 
membrane. Toynbee test was used in patients with perforated ear drum.
In our study we used AMPLAID Audiometer for testing Eustachian tube 
function in perforated drum and MAICO 34 for testing Eustachian tube 
function in intact tympanic membrane.80-85
William’s test
Middle ear pressure was measured at the start (resting pressure) ,
after patient swallows ( with nose and mouth closed) and after Valsalva 
manoeuvre. Normal ambient middle ear is usually slightly negative. 
63
Middle ear pressure becomes more negative on swallowing and becomes 
positive on Valsalva manoeuvre.
Interpretation :
1. 1.Partial impairment : Middle ear pressure becomes negative on 
swallowing  but it  doesn’t become positive on Valsalva or vice 
versa.
2. Gross impairment : Middle ear pressure doesn’t change for both 
swallowing and Valsalva.
William’s test printout showing gross impairment in right side and 
partial impairment in left side
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William’s test printout showing gross dysfunction in right side with 
normal tubal function in left side
Toynbee’s  test :
A negative or positive pressure ( - 250 or + 250 dapa ) is created in 
the middle ear and the patient is asked to swallow  5 times .  Change of 
air pressure in the middle ear is recorded each time when the patient 
swallows .The ability to equilibrate the pressure indicates normal tubal 
function. The test can also be used to find the patency of the grommet 
placed in the tympanic membrane in cases of serous otitis media. 
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Interpretation :
1. Normal Eustachian tube function - The pressure built up by the 
impedance audiometer completely neutralized by repeated 
swallowing.
2. Partial impairment – Persisting of  some residual pressure even 
after five swallows 
3. Gross impairment  - if the pressure built up by the impedance 
audiometer cannot be neutralized at all by repeated swallowing.
Toynbee‘s test showing gross impairment of tubal function
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Toynbee’s test showing normal tubal function in patient with dry 
perforation
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RESULTS AND ANALYSIS
This study was performed to find the functioning of Eustachian 
tube in normal adults and those with middle ear disease. This study was 
done in department of ENT, Coimbatore Medical College & Hospital,  
Coimbatore in patients with normal tympanic membrane, chronic otitis 
media patients with dry central perforation, patients with retracted 
tympanic membrane and in patients with healed central perforation. Post 
operative patients who underwent myringoplasty and type 1 
tympanoplasty were also tested for Eustachian tube function. 
Eustachian  tube  function  was  assessed  by  Valsalva test, 
pneumatic otoscopy (siegalization), nasopharyngoscopy, tympanometry.  
Eustachian tube function was assessed with impedance audiometer 
with two tests. William’s test was done in patients with intact tympanic 
membrane. Toynbee test was used in patients with perforated ear drum. 
Control group was 50 normal adults in the age of 18 to 49 who were 
tested for  Eustachian tube function. Out of 50 only one had partial ET 
dysfunction(2%). 
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Study group was 50 patients with dry central perforation of which 
7 were post operative patients with failed tympanoplasty. Among 43 
CSOM  patients  26  had  ET dysfunction (60.4 %). In 7 patients with 
residual Central perforation , 6 had  ET dysfunction (85.71%) suggesting 
ET dysfunction as the important cause for failure of surgery. No 
significant age or gender difference in Eustachian tube dysfunction  
found.
As part of study 30 adults with retracted tympanic membrane and 8 
patients with healed CP were tested for Eustachian tube function.In 
patients with retracted Tympanic membrane, ET dysfunction was 
identified in 27 patients (90 %) of which 21 had partial and 6 had gross 
dysfunction suggesting ET dysfunction as a major factor for chronic 
retraction.
In 7 out of 8 patients with healed tympanic membrane perforation 
ET function tests were normal suggesting that good Eustachian tube 
functioning plays a prominent role in the healing of tympanic membrane 
perforation.
12 patients who had undergone myringoplasty or type 1 
tympanoplasty were tested for Eustachian tube functioning.10 patients 
(83 %) were found to have normal ET functioning while 2 had partial 
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tubal dysfunction suggesting that ET function tests are an important 
prognostic indicator for success of surgery.
Statistical analysis was done for all variables in the study using 
NCSS software . The data was analysed for mean, standard deviation, 
range and percentage.The chi-square and student’s unpaired t tests were 
used for comparison between study and control groups.
Interpreting p-values was considered in the following manner.
Not Significant > 0.05
Significant < 0.05
Very Significant < 0.01
Highly Significant < 0.001
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Table 1 :AGE DISTRIBUTION
Age in years No.of  normal adults
No.of patients with 
dry Central 
perforation
18 - 20 4 4
21 - 25 11 7
26 - 30 12 7
31 - 35 8 8
36 - 40 6 12
41 - 45 7 8
46 - 49 2 4
TOTAL 50 50
Line diagram showing age distribution of  normal adults 
and patients with dry CP
0
2
4
6
8
10
12
14
18-20 21-25 26-30 31-35 36-40 41-45 46-49 
NORMAL
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TABLE 2 :SEX DISTRIBUTION
SEX Normal Adults
Patients With Dry 
Central Perforation
Male 26 29
Female 24 21
Bar diagram depicting the sex distribution of  normal adults and 
patients with dry central perforation
0
5
10
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30
35
normal patients
male
female
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TABLE 3  : Age distribution of patients with retracted tympanic 
membrane ,patients with healed central perforation and post 
operative patients with neomembrane
Age ( in years )
Retracted 
tympanic 
membrane
Healed central 
perforation
Post operative 
patients with 
neomembrane
18-20 5 1 1
21-25 3 2 2
26-30 7 2
31-35 5 1 4
36-40 4 2 1
41-45 4 2 1
46-49 2 1
Total 30 8 12
Line  Diagram Showing Age Distribution Of Patients With Retracted 
Tympanic Membrane ,Patients With Healed Central Perforation 
And Post Operative Patients With Neomembrane
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TABLE 4 : Sex distribution of patients  with retracted tympanic 
membrane ,patients with healed central perforation and post 
operative patients with neomembrane
Sex
Retracted 
tympanic 
membrane
Healed central 
perforation
Post operative 
patients with 
neomembrane
Male 16 4 6
Female 14 4 6
Total 30 8 12
Bar Diagram Showing Sex distribution of patients  with retracted 
tympanic membrane ,patients with healed central perforation and 
post operative patients with neomembrane
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RETRACTION HEALED CP POST OP
MALE 
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TABLE 5:  TYMPANIC MEMBRANE STATUS
Tympanic  Membrane  Status No.of patients
Central perforation 50
Healed Central perforation 8
Post op neomembrane 12
Retraction (grade 1 & 2 ) 30
Pie Chart Depicting The Tympanic Membrane Status In Patients 
With Middle Ear Disease
Tympanic membrane status
DRY CP
HEALED CP
NEOMEMBRANE
RETRACTION
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Table  6  : Surgical Status Of Patients With Chronic Otitis Media
Sl.no Patients with COM No of patients
1 Non Operated 43
2 Operated With Residual Central 
perforation Or Recurrent 
Disease
7
Pie chart showing surgical status of patients with chronic otitis media  
NOT OPERATED
POST OP
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Table  7 : Eustachian tube function in patients with CSOM
NORMAL
TUBAL 
FUNCTION
PARTIAL ET 
DYSFUNCTION
GROSS TUBAL
DYSFUNCTION
PATIENTS WITH  DRY 
CP (NOT OPERATED)
43 17 14 12
POST OP PATIENTS 
WITH   RESIDUAL CP
7 1 3 3
TOTAL 50 18 17 15
Bar diagram showing Eustachian tube function  
in patients with CSOM
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TABLE  8    Normal Adults Vs Patients With Dry Central 
Perforation
TOTAL
Normal 
ETF
Eustachian tube 
dysfunction
Percentage
( normal ETF )
NORMAL
ADULTS
50 49 1 98%
PATIENTS WITH 
DRY CP
50 18 32 36 %
Chi-square with Yates correction
Chi squared equals 40.706 with 1 degrees of freedom. The two-tailed P 
value is less than 0.0001 . The association between  COM  and  ETF   is 
considered to be extremely statistically significant. 
Bar  Diagram  comparing  the  Eustachain tube  function  of  normal  
adults  with  CSOM patients with dry Central perforation
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TABLE 9 : Eustachian tube function in patients with Retracted 
Tympanic membrane, Healed Central perforation, Post op patients
Sl.no Patients
No of 
pts
Normal 
ETF
Eustachian tube 
dysfunction
Percentage
(normal 
ETF )Partial gross
1 Retracted 
tympanic 
membrane
30 3 21 6 10.0%
2 Healed 
central 
perforation
8 7 1 87.5%
3 Postop 
patients
12 10 2 83.3 %
Bar Diagram showing Eustachian tube function in patients with 
retracted Tympanic membrane,healed Central perforation,post op 
patients
0
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Retracted TM
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Table  10 : Eustachian tube function 
drum vs retracted membrane
PATIENTS
NORMAL  EAR DRUM
RETRACTED DRUM
Chi-square with Yates correction
degrees of freedom. The two
association between
tympanic membrane
significant. 
Bar Diagram Showing 
Normal Ear Drum Vs Retracted Membrane
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NORMAL TM
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in patients with normal ear 
Normal tubal 
function
Eustachian tube 
dysfunction
           49             1
             3            27
  - Chi squared equals 60.015 with 1 
-tailed P value is less than 0.0001 .
Eustachian tube function and Retraction of 
   is considered to be extremely statistically 
Eustachian tube function  In Patients With 
RETRACTED TM
NORMAL
tubal dysfunction
The 
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TABLE  11: Eustachian tube function in patients with recurrent 
CSOM  vs patients with healed central perforation
Chi-square with Yates correction - Chi  Squared  equals 5.368  with  1  
degrees of freedom. The two-tailed P value equals 0.0205 .The 
association  between  healing  of  central perforation and  Eustachian tube 
function  is considered to be statistically significant. 
Bar diagram  showing Eustachian tube function in patients with 
recurrent CSOM  vs patients with healed central perforation
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RECURRENT 
CSOM
1 6
HEALED CP 7 1
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TABLE 12 : Eustachian tube function in normal tympanic 
membrane vs patients with healed central perforation
Normal Eustachian 
tube function
Eustachian tube 
dysfunction
Normal Tympanic 
Membrane 49 1
Healed Central 
Perforation 7 1
Chi-square with Yates correction -  Chi squared equals 0.219 with 1 
degrees of freedom. The two-tailed P value equals 0.6400 . The p value is 
considered to be not statistically significant  suggesting that the  ETF in 
normal adults &  patients with healed central perforation  is  similar.
Bar Diagram Showing Eustachian tube function In Normal 
Tymapnic membrane  Vs Healed Central  perforation
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DISCUSSION
Eustachian tube function testing can be important tool for 
improving the success rate of tympanoplasty surgery. Earlier more 
importance was given for testing the anatomical patency of Eustachian 
tube. Merely testing the patency does not serve the purpose of identifying 
the physiological functioning of the tube.  Otologists    have started to test 
the functioning of Eustachian tube by testing the ability of the tube to 
regulate middle ear pressure. New impedence audiometers serve this 
purpose. In our study we used AMPLAID Audiometer for testing ETF in 
perforated drum and MAICO 34 for testing ETF in intact tympanic 
membrane.
Two tests were used. William’s  test for patients with intact 
tympanic membrane and Toynbee’s test for patients with perforation.
Elner et al in 1976 classified patients into four groups based on 
their ability to equilibrate middle ear pressure.
Group 1 – ability to  equilibrate both positive and negative pressure   
completely    
Group 2 - ability to  equilibrate both positive and negative   pressure   
Partially
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Group 3 - ability to  equilibrate positive and but  unable to  equilibrate  
negative pressure
Group 4 –could not equilibrate both positive & negative
Cantekin  et al86 in 1979 studied the Eustachian tube function in 6 
normal adults with traumatic perforation and in 5 adults with chronic 
perforation. He used inflation –deflation and forced response test for 
assessing ETF. Eustachian tube function was abnormal in chronic otitis 
media patients whereas it was normal in patients with traumatic 
perforation. In our study only 1 had partial tubal dysfunction out of 50 
normal adults whereas 32 out of 50 CSOM patients had tubal dysfunction 
.There was no significant age or gender difference in tubal dysfunction 
identified.17 male (53%) and 15 female (47%) had tubal dysfunction in 
our study.
Cohn et al .87 in 1979 tested tubal function by impedence 
audiometer in tympanoplasty patients. Success rate of surgery was only 
69% in patients with gross tubal dysfunction and 75% in patients with 
partial tubal dysfunction. Patients with normal ETF had graft uptake of 
95%.
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Sen et al88 in 1998 also used similar method of Toynbee’s test in 
perforated drum. Success rate of surgery was only 66% in patients with 
gross tubal dysfunction and 80% in patients with partial tubal 
dysfunction.
El –Guindy in 1993 had a success rate of 95% in patients with 
normal ETF. Success rate was 90% if the tubal pathology was corrected 
before tympanoplasty. The rate was only 68% in patients who tubal 
dysfunction and was not corrected before tympanoplasty.
Anirban Biswas89 in 1999 tested ETF using William’s test in 34 
post operative cases who were successfully treated by myringoplasty or 
type 1 typanoplasty. Out of 34 patients, 26 had perfectly normal function,
6 patients had partial impairment while only 2 had gross impairment. It
compares with our study where only 2 out of 12 patients had partial 
dysfunction. Anirban Biswas tested ET function using Toynbee’s test in 
83 patients with failed tympanoplasty . 83% of the patients had tubal 
dysfunction in our study, we did ET function test for 7 patients with 
failed tympanoplasty. Out of 7 patients, only 1 patient had normal 
function, 3 had partial dysfunction and 3 had gross impairment (85.7 %) 
suggesting that ET dysfunction is an important cause for failure of 
surgery.
85
Shreyas s.joshi et al in 2012 and Priya et al in 2012 also came up 
similar results when used tympanometry as a prognostic indicator of
myringoplasty and tympanoplasty.
In our study we had similar results .While the tubal function was 
normal in 7 of the 8 patients with healed perforation, Eustachian Tube 
function was impaired in 6 of the 7 patients with failed tympanoplasty.
Eustachian Tube function was normal in 10 out of 12 patients with 
successful  tympanoplasty.
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SUMMARY
In  our  study,  50  normal  adults  and  50  Chronic otitis media  
patients  with dry central  perforation  were  tested  for  Eustachian tube   
function. In normal adults out of 50 only 1 had partial  tubal  dysfunction.    
In  50  Chronic otitis media  patients  with  dry central perforation,   32  
patients  (64%)  had  Eustachian tube dysfunction  and  only  18  patients 
(36%)  had  normal  function.    On comparing  Eustachian tube  function  
in normal and Chronic otitis media  patients,  Eustachian tube dysfunction  
in  Chronic otitis media  patients is found  to  be  statistically  significant. 
As a part of the study eustachian tube function was also evaluated 
in   patients with retracted tympanic membrane ,healed central perforation 
and post operative patients who underwent myringoplasty or type 1 
tympanoplasty 7  out  of  8  [87.5%]  patients  with   healed   central   
perforation  and  10  out  12  [83%]   post  tympanoplasty patients   had  
normal tubal  function  suggesting  that normal functioning of Eustachian 
tube  function  plays  a  major   role  in  healing   of   the  perforation  and  
success  of  Tympanoplasty. 
In  30  patients  with  Grade   I &  II  retraction,  Eustachian tube  
dysfunction  was  found  in  27  patients.   On comparing  it  with  normal 
adults,  association   of  tubal  dysfunction   with retraction  was  found  to  
be  statistically  significant.    There   was  no  significant  age   or  gender  
difference  identified  in  patients  with  Eustachian   tube  dysfunction.
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CONCLUSION
From our study it is evident that Eustachian tube dysfunction is an 
important factor that determines the outcome of chronic otitis media. In 
most patients with healed central perforation and in post operative 
patients who were successfully treated by surgery, the Eustachian tube 
function was found to be normal. ET function was found to be partially or 
grossly impaired in most patients with recurrent or residual CP. In most 
of the CSOM patients and patients with retracted ear drum also the 
impairment of Eustachian tube function was found to be statistically 
significant. Chronic sinusitis, allergic rhinitis and smoking were the 
important causes of ET dysfunction.
Mucosal disease is the leading cause of ET dysfunction and a 
careful search for the underlying aetiology can be effective in directing 
specific treatment to resolve or mediate the ear sequelae. When medical 
treatment is inadequate, surgical intervention may be indicated. 
Tympanostomy tubes have a long proven record of efficacy but repeated 
insertion may lead to tympanic membrane pathology. Adenoidectomy 
may be effective, especially in children or in adults with significant 
hypertrophy compromising the tubal dilation. Eustachian tuboplasty is a 
new treatment to widen the tubal orifice and aid the valve in dilation 
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when medical and conventional surgical procedures have proven 
inadequate. But the method of Eustachian tuboplasty is yet to be 
standardized. Further studies are needed before it finds universal 
acceptance.
Eustachian tube function testing by impedance audiometry is a 
simple non-invasive method of testing the Eustachian tube function and 
helps in identifying the tubal dysfunction. Patients with tubal dysfunction 
should be evaluated for underlying cause and treatable causes should 
addressed before proceeding for surgery as it increases the success rate of 
tympanoplasty.
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PROFORMA
NAME :
AGE : 
SEX:
OCCUPATION:
ADDRESS:
SOCIOECONOMIC  STATUS:
HOSPITAL  OP/IP  NUMBER:
PRESENTING  COMPLAINTS :
     1. EAR BLOCK
 SIDE
 DURATION
 ONSET 
 AGGRAVATING       /
RELIEVING FACTORS
     2.EAR DISCHARGE
 SIDE
 DURATION
 TYPE
 ONSET 
 QUANTITY
 SMELL
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 AGGRAVATING       /
RELIEVING FACTORS
3.HARD  OF  HEARING:
 ONSET
 SIDE
 DURATION
 PROGRESSIVE  OR  NOT
 FLUCTUATING  OR  NOT
 HISTORY OF EAR DISCHARGE
 HISTORY  OF OTOTOXIC  
DRUGS
 HISTORY  OF TRAUMA
 AUTOPHONY
4.OTALGIA
 SIDE
 DURATION
 ONSET 
 AGGRAVATING       /
RELIEVING FACTORS
ASSOCIATED  SYMPTOMS
 TINNITUS
 VERTIGO
 HEAD ACHE
104
 NASAL  OBSTRUCTION
 POST NASAL DISCHARGE
 RECURRENT  ATTACKS  OF 
UPPER  RESPIRATORY  TRACT  
INFECTIONS
         PAST  HISTORY
 ALLERGY
 ASTHMA
 TRAUMA
 OTOTOXIC  DRUGS
 PREVIOUS   EAR  SURGERY
 IRRADIATION
 HYPERTENSION
 DIABETES 
 PULMONARY  TB
PERSONAL  HISTORY
 SMOKING
 ALCOHOLISM
 DIET
 BOWEL  AND  BLADDER  HABITS
FAMILY  HISTORY
 HARD  OF  HEARING
 HISTORY  OF  CONSANGUINOUS  MARRIAGE
105
SOCIO ECONOMIC    HISTORY
GENERAL  EXAMINATION
TEMPERATURE 
PULSE
BLOOD  PRESSURE
PALLOR
ICTERUS
CLUBBING
CYANOSIS
EDEMA
GENERALISED  LYMPHADENOPATHY
SYSTEMIC  EXAMINATION
 CARDIOVASCULAR  SYSTEM
 RESPIRATORY  SYSTEM
 CENTRAL  NERVOUS  SYSTEM
 GASTROINTESTINAL  SYSTEM
LOCAL  EXAMINATION
EXAMINATION  OF  EAR  :  RIGHT LEFT
PINNA
PRE  AURICULAR  REGION
POST AURICULAR  REGION
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EXTERNAL  AUDITORY  CANAL
MASTOID  REGION
TRAGAL  SIGN
TYMPANIC  MEMBRANE
PARS TENSA
PARS  FLACCIDA
HANDLE  OF  MALLEUS
COLOUR 
CONE  OF LIGHT
RETRACTED  OR  NOT
MOBILITY
TUNING  FORK  TESTS
RINNE  TEST
WEBER  TEST
ABSOLUTE  BONE  CONDUCTION
THREE  FINGER  TEST
FACIAL  NERVE
FISTULA  SIGN
VESTIBULAR  FUNCTION  TESTS
107
EXAMINATION  OF  NOSE
 ANTERIOR  RHINOSCOPY
 POST  NASAL  EXAMINATION
EXAMINATION  OF  THROAT
INVESTIGATIONS
Pure  Tone  Audiometry
Impedence  Audiometry
Video  otoscopy
Diagnostic  Nasal  Endoscopy 
Pneumatic  otoscopy
William’s test in intact tympanic membrane
Toynbee’s test in perforated ear drum
CT  Scan  of paranasal   sinuses  (in  selected   cases)
MASTER CHART – CONTROL GROUP (NORMAL ADULTS )
               HISTORY TM PTA ETF
S.No. Name Age Sex E B E D HOH SURG EAR OTOSCOPY MO ETO RT LT IMP NL PD GD
1 BHUVANESWARI 24 F - - - - BOTH   NL + NL 13 16   A   + - -
2 RAJENDRAN 29 M - - - - BOTH   NL + NL 16 17   A   + - -
3 KAVITHA 23 F - - - - BOTH   NL + NL 13 13   A   + - -
4 HARINI 19 F - - - - BOTH   NL + NL 18 18   A   + - -
5 SURYA 31 F - - - - BOTH   NL + NL 16 17   A   + - -
6 TINU MARIYA 22 F - - - - BOTH   NL + NL 17 15   A   + - -
7 VELUSAMY 26 M - - - - BOTH   NL + NL 13 13   A   + - -
8 PALANIYAPPAN 34 M - - - - BOTH   NL + NL 15 15   A   + - -
9 BALAKRISHNAN 19 M - - - - BOTH   NL + NL 13 15   A   + - -
10 KALAVATHI 25 F - - - - BOTH   NL + NL 15 18   A   + - -
11 AKBAR 27 M - - - - BOTH   NL + NL 13 15   A   + - -
12 SAKTHEESH 24 M - - - - BOTH   NL + NL 17 16   A + - -
13 ANNE MARIA 23 F - - - - BOTH   NL + NL 16 16   A   + - -
14 PADMA 41 F - - - - BOTH   NL + NL 13 13   A   + - -
15 SYED 
MOHAMMED
18 M - - - - BOTH   NL + NL 15 13   A   + - -
16 ANGELINE 36 F - - - - BOTH   NL + NL 13 13   A   + - -
17 BETHU 25 M - - - - BOTH   NL + NL 13 15   A   + - -
18 RANJITH 38 M - - - - BOTH   NL + NL 17 18   A   + - -
19 PRIYARANJINI 20 F - - - - BOTH   NL + NL 16 17   A   + - -
20 SHAHUL HAMEED 24 M - - - - BOTH   NL + NL 17 18   A   + - -
21 RAMATHAL 23 F - - - - BOTH   NL + NL 16 17   A   + - -
22 CHITHRA 43 F - - - - BOTH   NL + NL 16 13   A   + - -
23 SARAVANAKUMAR 33 M - - - - BOTH   NL + NL 13 16   A   + - -
24 ANEESH 27 M - - - - BOTH   NL + NL 17 16   A   + - -
25 JOSEPH 42 M - - - - BOTH   NL + NL 16 16   A   + - -
MASTER CHART – CONTROL GROUP (NORMAL ADULTS )
HISTORY TM PTA ETF
S.No. Name Age Sex E B E D HOH SURG EAR OTOSCOPY MO ETO RT LT IMP NL PD GD
26 DEVIKA 44 F - - - - BOTH NL + NL 13 13 A + - -
27 RAMYA 31 F - - - - BOTH NL + NL 15 16 A + - -
28 KARAMATH 24 M - - - - BOTH NL + NL 18 22 C - + -
29 JANARTHAN 47 M - - - - BOTH NL + NL 15 15 A + - -
30 KRITHIKA 22 F - - - - BOTH NL + NL 12 15 A + - -
31 MADHU 35 M - - - - BOTH NL + NL 15 13 A + - -
32 SANJANA 28 F - - - - BOTH NL + NL 18 18 A + - -
33 MARUTHU 37 M - - - - BOTH NL + NL 16 17 A + - -
34 ELANGOVAN 29 M - - - - BOTH NL + NL 16 16 A + - -
35 ELIZABETH 34 F - - - - BOTH NL + NL 13 16 A + - -
36 MANIKANDAN 36 M - - - - BOTH NL + NL 17 16 A + - -
37 KANNAN 26 M - - - - BOTH NL + NL 16 13 A + - -
38 MARIMUTHU 33 M - - - - BOTH NL + NL 13 15 A + - -
39 DIVYA 26 F - - - - BOTH NL + NL 18 18 A + - -
40 GURUMANI 38 M - - - - BOTH NL + NL 16 13 A + - -
41 SHAKTHIPRIYA 27 F - - - - BOTH NL + NL 15 16 A + - -
42 ANUPRIYA 35 F - - - - BOTH NL + NL 17 18 A + - -
43 SARASWATHY 29 F - - - - BOTH NL + NL 18 18 A + - -
44 MOHAMED 
ISMAIL
48 M - - - - BOTH NL + NL 16 15 A + - -
45 CHELLAKAVITHA 26 F - - - - BOTH NL + NL 12 13 A + - -
46 VIJAYALAKSHMI 40 F - - - - BOTH NL + NL 13 15 A + - -
47 HARISH 30 M - - - - BOTH NL + NL 15 16 A + - -
48 DHANALAKSHMI 45 F - - - - BOTH NL + NL 16 16 A + - -
49 CHELLAMUTHU 43 M - - - - BOTH NL + NL 18 17 A + - -
50 GNANASEKAR 41 M - - - BOTH NL + NL 15 15 A + - -
        MASTER CHART – STUDY  GROUP ( PATIENTS WITH COM )
HISTORY TM PTA ETF
S.No. Name Age Sex E B E D HOH SURG EAR OTOSCOPY MO ETO RT LT IMP NL PD GD
1 ANJUGAM 46 F - - + - RT CP NA NL 33 18 B + - -
2 MARIYA 31 F + - - - RT CP NA NL 28 15 B - + -
3 RAMAKRISHNAN 41 M - - + - LT CP NA NL 16 36 B - + -
4 CHELLAKAVITHA 27 F - - + - RT CP NA NR 43 16 B - - +
5 DURAI 21 M + - - - LT CP NA NL 13 23 B - + -
6 VINEETA 33 F - - + - RT CP NA NL 33 16 B + - -
7 RADIKA 36 F - - + - LT CP NA NL 13 38 B + - -
8 THANGAPPAN 47 M - - + - RT CP NA NL 33 17 B - + -
9 LORETTA 21 F - - + - LT CP NA NL 13 36 B - - +
10 MUKESH 26 M + - - - RT CP NA NL 26 15 B + - -
11 THAMARAI 34 F - - + - LT CP NA NL 36 38 B - + -
12 ABU THAKEER 42 M - - + - RT CP NA NR 43 36 B - - +
13 VETRISELVI 36 F - - + - RT CP NA NL 42 18 B - + -
14 FATHIMA 49 F - - + - LT CP NA NL 15 35 B - + -
15 VIGNESH 23 M + - - - LT CP NA NL 16 30 B - - +
16 SURESH 28 M - - + - LT CP NA NL 16 43 B - + -
17 SRIDIVYA 18 F + - + - RT CP NA NL 36 18 B - + -
18 SETHUPATHI 22 M - - + - LT CP NA NL 16 53 B + - -
19 ULAGANATHAN 35 M - - + - RT CP NA NL 46 38 B - + -
20 VEERALAKSHMI 44 F + - - - RT CP NA NL 31 15 B - + -
21 PUSHPARAJ 19 M + - - - LT CP NA NR 13 28 B - - +
22 SALEEM 37 M - - + - RT CP NA NL 35 16 B - - +
23 MOHAN 33 M - - + - RT CP NA NL 33 18 B + - -
24 SUNDARAM 43 M - - + - LT CP NA NL 18 45 B + - -
25 THIYAGARAJAN 40 M - - + - RT CP NA NL 46 36 B + - -
                                                     MASTER CHART – STUDY  GROUP ( PATIENTS WITH COM )
HISTORY TM PTA ETF
S.No. Name Ag
e
Sex E B E D HOH SURG EAR OTOSCOPY MO ET
O
RT LT IMP NL PD GD
26 HARIHARAN 40 M + - - - RT CP NA NL 26 18 B + - -
27 KALAIYARASU 19 M - - + - LT CP NA NL 15 33 B - - +
28 ALAGAMMAL 41 F - - + - LT CP NA NL 13 36 B - - +
29 KRISHNAN 37 M - - + - RT CP NA NL 43 15 B - + -
30 SAMYUKTHA 27 F - - + - RT CP NA NL 45 18 B + - -
31 ANURADHA 45 F + - - - LT CP NA NL 16 31 B - + -
32 SIVA 23 M - - + - RT CP NA NL 43 38 B + - -
33 KUPPUSAMY 39 M - - + - RT CP NA NL 38 16 B + - -
34 SIMIONE 30 M - - + - RT CP NA NL 36 33 B - + -
35 ILAVARASI 44 F - - + - LT CP NA NR 15 54 B - - +
36 VASANTHI 47 F - - + - RT CP NA NL 46 15 B + - -
37 MUTHUKUMAR 26 M + - - - LT CP NA NL 13 28 B + - -
38 SENTHIL 37 M - - + - RT CP NA NL 31 31 B - - +
39 MOHAIDEEN 31 M - - + - LT CP NA NL 33 36 B + - -
40 KALARATHI 36 F - - + - RT CP NA NR 40 18 B - - +
41 SELVAPEUMAL 18 M - - + - LT CP NA NL 13 32 B + - -
42 ALVIN 22 M - - + - LT CP NA NL 16 51 B - - +
43 SUGANTHI 34 F - - + - LT CP NA NL 13 35 B + - -
44 VINOD 43 M + - - + RT CP NA NL 30 18 B - + -
45 ANWAR 40 M - - + + LT CP NA NL 16 36 B + - -
46 SHAKILA 35 F - - + + LT CP NA NL 15 41 B - - +
47 ARUN KUMAR 38 M - - + + RT CP NA NL 38 18 B - - +
48 VISHALI 24 F + - - + LT CP NA NL 16 30 B - + -
49 DEVASAGAYAM 36 M - - + + RT CP NA NL 43 38 B - - +
50 JAYANTHI 29 F - - + + LT CP NA NL 33 33 B - + -
                                         MASTER     CHART   -  PATIENTS WITH RETRACTED TM,HEALED CP,POST OP PATIENTS
                                                                                        
                                         
HISTORY TM PTA ETF
S.No. Name Age Sex E B E D HOH SURG EAR OTOSCOPY MO ETO RT LT IMP NL PD GD
1 PUGAZHENTHI 19 M + - - - RT RETRACTED + NL 18 20 C - + -
2 ANBARASAN 31 M + - - - LT RETRACTED + NL 16 19 C - + -
3 VIMALARANI 42 F + - - - RT RETRACTED + NL 20 18 A + - -
4 AVIN KUMAR 20 M + - - - LT RETRACTED + NR 15 19 C - - +
5 LEELAVATHI 26 F - - + - BOTH RETRACTED + NL 28 26 C - + -
6 DHANYA JOBY 27 F + - - - RT RETRACTED + NR 20 18 C - - +
7 SELVAKUMAR 43 M + - - - LT RETRACTED + NL 20 21 C - + -
8 VENKATESH 38 M - - + - BOTH RETRACTED + NL 21 24 A + - -
9 SADHANA 34 F + - - - RT RETRACTED + NL 20 16 C - + -
10 BHARATHI 30 M + - - - LT RETRACTED + NL 15 21 C - + -
11 SUJITHA 23 F + - - - BOTH RETRACTED + NL 23 21 C - - +
12 GREESHMA 27 M + - - - RT RETRACTED + NL 20 16 C - + -
13 SUDHARSHAN 33 M + - + - LT RETRACTED + NL 18 30 C - + -
14 AISHWARYA 18 F + - - - RT RETRACTED + NL 18 15 C - + -
15 MANIKANDAN 37 M + - - - RT RETRACTED + NL 23 16 A - + -
16 DURGADEVI 37 F - - - - LT RETRACTED + NL 16 21 C + - -
17 AMUL RAJULU 43 M + - - - RT RETRACTED + NL 18 13 C - + -
18 SOWMIKA 32 F + - - - LT RETRACTED + NL 15 15 C - + -
19 GOKUL 29 M + - - - RT RETRACTED + NR 23 15 C - - +
20 DHARSHINISHREE 22 F + - - - LT RETRACTED + NL 16 20 C - + -
21 SENTHILNATHAN 24 M + - + - BOTH RETRACTED + NL 24 26 A - - +
22 PRATUKSHA 18 F + - - - LT RETRACTED + NL 16 20 C - + -
23 JENNIFER 49 F + - - - RT RETRACTED + NL 18 16 A - + -
24 RAMACHANDRAN 46 M + - - - LT RETRACTED + NL 13 21 C - + -
25 LIBINA 
AUGUSTINE
29 F + - - - LT RETRACTED + NL 14 18 A - + -
                                       MASTER     CHART   -  PATIENTS WITH RETRACTED TM,HEALED CP,POST OP PATIENTS
HISTORY TM PTA ETF
S.No. Name Age Sex E B E D HOH SURG EAR OTOSCOPY MO ETO RT LT IMP NL PD GD
26 SHARON 26 F + - - - RT RETRACTED + NL 18 16 C - + -
27 MURUGESHAN 41 M + - - - LT RETRACTED + NL 15 16 A - + -
28 JENNIFER 37 F - - + - BOTH RETRACTED + NR 21 24 C - - +
29 SYED KEZAR 18 M + - - - BOTH RETRACTED + NR 18 21 C - + -
30 SIVAKUMAR 35 M + - - - RT RETRACTED + NL 19 15 A - + -
1 ANJU GRACE 20 F - - - - LT HEALED CP + NL 16 16 A + - -
2 RADHA 25 F - - - - RT HEALED CP + NL 15 13 A + - -
3 ARUMUGAM 38 M + - - - RT HEALED CP + NL 17 16 C - + -
4 RAMYASHREE 23 F - - - - LT HEALED CP + NL 16 16 A + - -
5 PERIYASAMY 45 M + - - - RT HEALED CP + NL 23 18 C + - -
6 MALA 42 F - - - - LT HEALED CP + NL 16 15 A + - -
7 GURUSAMY 39 M - - - - LT HEALED CP + NL 13 15 A + - -
8 BASHEER 33 M - - - - RT HEALED CP + NL 17 18 A + - -
1 MATHEW 28 M - - + + LT NEOMEMBRANE + NL 35 18 A + - -
2 SHEELA 32 F + - + + RT NEOMEMBRANE + NL 21 45 C - + -
3 IRFAN 19 M - - - + LT NEOMEMBRANE + NL 16 17 C + - -
4 CHANDRAMOHAN 33 M + - - + LT NEOMEMBRANE + NR 18 24 C - + -
5 NISHA KURIAKOSE 32 F - - - + LT NEOMEMBRANE + NL 13 13 A + - -
6 DAMAYANTHI 43 F - - + + RT NEOMEMBRANE + NL 18 38 A + - -
7 PALANINATHAN 47 M - - - + RT NEOMEMBRANE + NL 16 16 A + - -
8 THULASI 38 F - - - + LT NEOMEMBRANE + NL 15 18 A + - -
9 PATTUROSE 24 F - - + + RT NEOMEMBRANE + NL 18 46 C + - -
10 NAVEEN 29 M - - - + LT NEOMEMBRANE + NL 16 18 A + - -
11 JAYAPAL 21 M - - - + LT NEOMEMBRANE + NL 15 15 A + - -
12 AARTHI 32 F - - - + RT NEOMEMBRANE + NL 18 12 A + - -
                                                                       KEY TO MASTER CHART
S.NO Serial  Number
M Male
F Female
HOH Hard  Of  Hearing
EB Ear Block
ED Ear Discharge
TM Tympanic membrane
MO Mobilty Of Tympanic Membrane
ETO Eustachian tube opening in nasopharynx
NL Normal 
NR Narrow
PTA Pure tone audiogram
RT Right 
LT Left 
IMP Impedance audiometry
ETF Eustachian Tube Function
PD Partial dysfunction
GD Gross dysfunction
MAICO 34 AUDIOMETER  FOR   EUSTACHIAN  TUBE  
FUNCTION BY  WILLIAM'S TEST
WILLIAM’S TEST MEASURING MIDDLE EAR PRESSURE 
WHILE THE PATIENT  SWALLOWS  WITH  THE NOSE 
CLOSED
WILLIAM’S TEST MEASURING MIDDLE EAR PRESSURE 
WHEN THE PATIENT DOES  VALSALVA MANOUEVRE
PNEUMATIC OTOSCOPY
RIGHT EUSTACHIAN TUBE OPENING IN OPEN STATE
RIGHT EUSTACHIAN TUBE OPENING IN CLOSED STATE
NORMAL RIGHT TYMPANIC MEMBRANE
DRY CENTRAL PERFORATION  IN RIGHT CSOM PATIENT
RETRACTED LEFT TYMPANIC  MEMBRANE
HEALED CENTRAL PERFORATION -  RIGHT TYMPANIC 
MEMBRANE
TYMPANIC MEMBRANE – POST MYRINGOPLASTY
WILLIAM’S TEST PRINTOUT SHOWING NORMAL 
EUSTACHIAN TUBE FUNCTION IN BOTH EARS
WILLIAM’S TEST PRINTOUT SHOWING NORMAL 
EUSTACHIAN TUBE FUNCTION IN RIGHT  EAR  AND A FLAT 
CURVE IN PATIENT WITH LEFT CSOM
WILLIAM’S TEST PRINTOUT SHOWING PARTIAL EUSTACHIAN 
TUBE DYSFUNCTION IN LEFT EAR WITH NORMAL FUNCTION 
IN RIGHT EAR
TOYNBEE TEST PRINTOUT SHOWING NORMAL EUSTACHIAN 
TUBE FUNCTION IN PATIENT WITH  LEFT CSOM
TOYNBEE TEST PRINTOUT SHOWING PARTIAL EUSTACHIAN 
TUBE DYSFUNCTION IN PATIENT WITH  LEFT CSOM
